Non-coding RNA influences in dementia

World Alzheimer Report 2015, the Global Impact of Dementia: an Analysis of Prevalence, Incidence, Cost and Trends, (n.d.) 87. Wimo, 2017, The worldwide costs of dementia 2015 and comparisons with 2010, Alzheimers Dement. J. Alzheimers Assoc., 13, 1, 10.1016/j.jalz.2016.07.150 WHO, The World Health Report 2003 - Shaping the Future, WHO. (n.d.). http://www.who.int/whr/2003/en/(Accessed 27 August 2018). Barker, 2002, Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida brain bank, Alzheimers Dis. Assoc. Disord., 16, 203, 10.1097/00002093-200210000-00001 Gomez-Isla, 2008, Neuropathology of Alzheimer's disease, Handb. Clin. Neurol., 89, 233, 10.1016/S0072-9752(07)01222-5 Bignante, 2013, Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease, Neurobiol. Aging, 34, 2525, 10.1016/j.neurobiolaging.2013.04.021 Plummer, 2016, The neuroprotective properties of the amyloid precursor protein following traumatic brain injury, Aging Dis, 7, 163, 10.14336/AD.2015.0907 Habib, 2017, Restoring soluble amyloid precursor protein α functions as a potential treatment for Alzheimer's disease, J. Neurosci. Res., 95, 973, 10.1002/jnr.23823 Vassar, 2009, The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential, J. Neurosci. Off. J. Soc. Neurosci., 29, 12787, 10.1523/JNEUROSCI.3657-09.2009 De Strooper, 2010, The secretases: enzymes with therapeutic potential in Alzheimer disease, Nat. Rev. Neurol., 6, 99, 10.1038/nrneurol.2009.218 Bodily, 2016, Alzheimer's Disease Neuroimaging Initiative, A novel approach for multi-SNP GWAS and its application in Alzheimer's disease, BMC Bioinf., 17, 268, 10.1186/s12859-016-1093-7 Freudenberg-Hua, 2018, The role of genetics in advancing precision medicine for Alzheimer's disease-A narrative review, Front. Med., 5, 108, 10.3389/fmed.2018.00108 Zhao, 2015, Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance, Nat. Neurosci., 18, 978, 10.1038/nn.4025 Crocker, 2007, Siglecs and their roles in the immune system, Nat. Rev. Immunol., 7, 255, 10.1038/nri2056 Griciuc, 2013, Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta, Neuron, 78, 631, 10.1016/j.neuron.2013.04.014 Duncan, 2018, Presenilins as drug targets for Alzheimer's disease-recent insights from cell biology and electrophysiology as novel opportunities in drug development, Int. J. Mol. Sci., 19, 10.3390/ijms19061621 Mattson, 1998, Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease, J. Neurochem., 70, 1, 10.1046/j.1471-4159.1998.70010001.x Hernández-Zimbrón, 2015, Oxidative stress caused by ozone exposure induces β-amyloid 1-42 overproduction and mitochondrial accumulation by activating the amyloidogenic pathway, Neuroscience, 304, 340, 10.1016/j.neuroscience.2015.07.011 Nikolakopoulou, 2016, Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations, Neurobiol. Aging, 42, 41, 10.1016/j.neurobiolaging.2016.02.028 Ebrahimie, 2016, The zebrafish equivalent of Alzheimer's disease-associated PRESENILIN isoform PS2V regulates inflammatory and other responses to hypoxic stress, J. Alzheimers Dis. JAD., 52, 581, 10.3233/JAD-150678 McMains, 2010, Dictyostelium possesses highly diverged presenilin/gamma-secretase that regulates growth and cell-fate specification and can accurately process human APP: a system for functional studies of the presenilin/gamma-secretase complex, Dis. Model. Mech., 3, 581, 10.1242/dmm.004457 Neely, 2011, Presenilin is necessary for efficient proteolysis through the autophagy-lysosome system in a γ-secretase-independent manner, J. Neurosci. Off. J. Soc. Neurosci., 31, 2781, 10.1523/JNEUROSCI.5156-10.2010 Southon, 2013, Presenilin promotes dietary copper uptake, PloS One, 8, 10.1371/journal.pone.0062811 Vance, 2000, The synthesis and transport of lipids for axonal growth and nerve regeneration, Biochim. Biophys. Acta, 1486, 84, 10.1016/S1388-1981(00)00050-0 Kim, 2014, Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms, Mol. Cell., 37, 767, 10.14348/molcells.2014.0248 Belbin, 2007, Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease, Hum. Mol. Genet., 16, 2199, 10.1093/hmg/ddm171 Saunders, 1993, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467 Marottoli, 2017, Peripheral inflammation, apolipoprotein E4, and amyloid-β interact to induce cognitive and cerebrovascular dysfunction, ASN Neuro, 9, 10.1177/1759091417719201 Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat. Rev. Neurol., 9, 106, 10.1038/nrneurol.2012.263 Yin, 2012, Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis, Neurosci. Lett., 514, 6, 10.1016/j.neulet.2012.02.031 McCusker, 2001, Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study, Lancet Lond. Engl., 357, 436, 10.1016/S0140-6736(00)04008-3 Kim, 2006, The gene encoding transforming growth factor beta 1 confers risk of ischemic stroke and vascular dementia, Stroke, 37, 2843, 10.1161/01.STR.0000244782.76917.87 Fung, 2005, Heat shock protein 70 and tumor necrosis factor alpha in Taiwanese patients with dementia, Dement. Geriatr. Cognit. Disord., 20, 1, 10.1159/000085067 Rohrer, 2009, The heritability and genetics of frontotemporal lobar degeneration, Neurology, 73, 1451, 10.1212/WNL.0b013e3181bf997a Seelaar, 2011, Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review, J. Neurol. Neurosurg. Psychiatry, 82, 476, 10.1136/jnnp.2010.212225 Ghetti, 2015, Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging, Neuropathol. Appl. Neurobiol., 41, 24, 10.1111/nan.12213 Olszewska, 2016, Genetics of frontotemporal dementia, Curr. Neurol. Neurosci. Rep., 16, 107, 10.1007/s11910-016-0707-9 Zarranz, 2004, The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol., 55, 164, 10.1002/ana.10795 Ross, 2006, Lrrk2 and Lewy body disease, Ann. Neurol., 59, 388, 10.1002/ana.20731 Ishikawa, 2005, A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease, Ann. Neurol., 57, 429, 10.1002/ana.20393 Piscopo, 2008, A novel PSEN2 mutation associated with a peculiar phenotype, Neurology, 70, 1549, 10.1212/01.wnl.0000310643.53587.87 Guyant-Marechal, 2008, Intrafamilial diversity of phenotype associated with app duplication, Neurology, 71, 1925, 10.1212/01.wnl.0000339400.64213.56 Ohtake, 2004, Beta-synuclein gene alterations in dementia with Lewy bodies, Neurology, 63, 805, 10.1212/01.WNL.0000139870.14385.3C Guerreiro, 2016, Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases, Neurobiol. Aging, 38, 214, 10.1016/j.neurobiolaging.2015.10.028 Wiseman, 2018, Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP, Brain J. Neurol., 10.1093/brain/awy159 Xu, 2015, Meta-analysis of modifiable risk factors for Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry, 86, 1299 Vassallo, 2013, Mediterranean diet and dementia of the Alzheimer type, Curr. Aging Sci., 6, 150, 10.2174/1874609811306020003 Summers, 2006, Tacrine, and Alzheimer's treatments, J. Alzheimers Dis. JAD., 9, 439, 10.3233/JAD-2006-9S350 Trinh, 2003, Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis, J. Am. Med. Assoc., 289, 210, 10.1001/jama.289.2.210 Johnson, 2006, Mechanism of action of memantine, Curr. Opin. Pharmacol., 6, 61, 10.1016/j.coph.2005.09.007 Reisberg, 2003, Memantine in moderate-to-severe Alzheimer's disease, N. Engl. J. Med., 348, 1333, 10.1056/NEJMoa013128 Smith, 2000, Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?, Curr. Opin. Investig. Drugs Lond. Engl., 4, 826 O'Brien, 2017, Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British Association for Psychopharmacology, J. Psychopharmacol. Oxf. Engl., 31, 147, 10.1177/0269881116680924 Howard, 2015, Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses, Lancet Neurol., 14, 1171, 10.1016/S1474-4422(15)00258-6 McGuinness, 2016, Statins for the prevention of dementia, Cochrane Database Syst. Rev., 10.1002/14651858.CD003160.pub3 Heneka, 2015, Neuroinflammation in Alzheimer's disease, Lancet Neurol., 14, 388, 10.1016/S1474-4422(15)70016-5 Maki, 2012, Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on, Climacteric J. Int. Menopause Soc., 15, 256, 10.3109/13697137.2012.660613 Kryscio, 2017, Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADViSE), JAMA Neurol, 74, 567, 10.1001/jamaneurol.2016.5778 Dodge, 2008, A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline, Neurology, 70, 1809, 10.1212/01.wnl.0000303814.13509.db Matsunaga, 2015, Cholinesterase inhibitors for lewy body disorders: a meta-analysis, Int. J. Neuropsychopharmacol., 19 Young, 2018, Frontotemporal dementia: latest evidence and clinical implications, Ther. Adv. Psychopharmacol., 8, 33, 10.1177/2045125317739818 Di Mauro, 2018, The noncoding-RNA landscape in cardiovascular health and disease, Non-Coding RNA Res., 3, 12, 10.1016/j.ncrna.2018.02.001 Connelly, 2014, Control of oncogenic miRNA function by light-activated miRNA antagomirs, Methods Mol. Biol. Clifton NJ, 1165, 99, 10.1007/978-1-4939-0856-1_9 Ayers, 2017, Influence of microRNAs and long non-coding RNAs in cancer chemoresistance, Genes, 8, 10.3390/genes8030095 Cogswell, 2008, Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways, J. Alzheimers Dis. JAD., 14, 27, 10.3233/JAD-2008-14103 Hébert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression, Proc. Natl. Acad. Sci. U. S. A, 105, 6415, 10.1073/pnas.0710263105 Shioya, 2010, Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3, Neuropathol. Appl. Neurobiol., 36, 320, 10.1111/j.1365-2990.2010.01076.x Long, 2011, MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed, Biochem. Biophys. Res. Commun., 404, 889, 10.1016/j.bbrc.2010.12.053 Boissonneault, 2009, MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1, J. Biol. Chem., 284, 1971, 10.1074/jbc.M807530200 Du, 2017, miR-124 downregulates BACE 1 and alters autophagy in APP/PS1 transgenic mice, Toxicol. Lett., 280, 195, 10.1016/j.toxlet.2017.08.082 An, 2017, MiR-124 acts as a target for Alzheimer's disease by regulating BACE1, Oncotarget, 8, 114065, 10.18632/oncotarget.23119 Gong, 2017, miR-15b represses BACE1 expression in sporadic Alzheimer's disease, Oncotarget, 8, 91551, 10.18632/oncotarget.21177 Sleegers, 2010, Role of progranulin as a biomarker for Alzheimer's disease, Biomark. Med., 4, 37, 10.2217/bmm.09.82 Wang, 2010, miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease, Am. J. Pathol., 177, 334, 10.2353/ajpath.2010.091202 Sala Frigerio, 2013, Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease, Neurology, 81, 2103, 10.1212/01.wnl.0000437306.37850.22 Higaki, 2018, Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models, PloS One, 13, 10.1371/journal.pone.0196929 Ross, 2018, miRNA-431 prevents amyloid-β-induced synapse loss in neuronal cell culture model of Alzheimer's disease by silencing Kremen1, Front. Cell. Neurosci., 12, 87, 10.3389/fncel.2018.00087 Li, 2011, Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models, Neurosci. Lett., 487, 94, 10.1016/j.neulet.2010.09.079 Wang, 2010, miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor, Brain Res., 1357, 166, 10.1016/j.brainres.2010.08.023 Zovoilis, 2011, microRNA-34c is a novel target to treat dementias, EMBO J., 30, 4299, 10.1038/emboj.2011.327 Ma, 2017, MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease, Neurosci. Lett., 661, 57, 10.1016/j.neulet.2017.09.043 Zhang, 2018, MicroRNA-322 cluster promotes tau phosphorylation via targeting brain-derived neurotrophic factor, Neurochem. Res., 43, 736, 10.1007/s11064-018-2475-1 Zhang, 2017, miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease, J. Biosci., 42, 397, 10.1007/s12038-017-9698-1 Hadar, 2018, SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease, Sci. Rep., 8, 8465, 10.1038/s41598-018-26547-6 Chen, 2017, MicroRNA-195 prevents dendritic degeneration and neuron death in rats following chronic brain hypoperfusion, Cell Death Dis., 8 Liao, 2016, TDB protects vascular endothelial cells against oxygen-glucose deprivation/reperfusion-induced injury by targeting miR-34a to increase Bcl-2 expression, Sci. Rep., 6, 37959, 10.1038/srep37959 Pietrzak, 2016, Gene expression profiling of brain samples from patients with Lewy body dementia, Biochem. Biophys. Res. Commun., 479, 875, 10.1016/j.bbrc.2016.09.114 Nelson, 2018, MicroRNA expression patterns in human anterior cingulate and motor cortex: a study of dementia with Lewy bodies cases and controls, Brain Res., 1678, 374, 10.1016/j.brainres.2017.11.009 Rademakers, 2008, Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia, Hum. Mol. Genet., 17, 3631, 10.1093/hmg/ddn257 Jiao, 2010, MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia, PloS One, 5, 10.1371/journal.pone.0010551 Chen-Plotkin, 2012, TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways, J. Neurosci. Off. J. Soc. Neurosci., 32, 11213, 10.1523/JNEUROSCI.0521-12.2012 Zhang, 2013, Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations, PloS One, 8 Arrant, 2014, MicroRNA-124 modulates social behavior in frontotemporal dementia, Nat. Med., 20, 1381, 10.1038/nm.3768 Gascon, 2014, Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia, Nat. Med., 20, 1444, 10.1038/nm.3717 Jawaid, 2018, Memory decline and its reversal in aging and neurodegeneration involve miR-183/96/182 biogenesis, Mol. Neurobiol., 10.1007/s12035-018-1314-3 Kang, 2014, HuD regulates coding and noncoding RNA to induce APP→Aβ processing, Cell Rep., 7, 1401, 10.1016/j.celrep.2014.04.050 Liu, 2014, Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1-AS expression, Mol. Med. Rep., 10, 1275, 10.3892/mmr.2014.2351 Magistri, 2015, Transcriptomics profiling of Alzheimer's disease reveal neurovascular defects, altered amyloid-β homeostasis, and deregulated expression of long noncoding RNAs, J. Alzheimers Dis. JAD., 48, 647, 10.3233/JAD-150398 Sosińska, 2015, The double-edged sword of long non-coding RNA: the role of human brain-specific BC200 RNA in translational control, neurodegenerative diseases, and cancer, Mutat. Res. Rev. Mutat. Res., 766, 58, 10.1016/j.mrrev.2015.08.002 Zhang, 2018, Expression of BC1 impairs spatial learning and memory in Alzheimer's disease via APP translation, Mol. Neurobiol., 55, 6007, 10.1007/s12035-017-0820-z Gu, 2018, Long noncoding RNA EBF3-AS promotes neuron apoptosis in Alzheimer's disease, DNA Cell Biol., 37, 220, 10.1089/dna.2017.4012 Guo, 2018, Silencing of LncRNA BDNF-AS attenuates Aβ25-35-induced neurotoxicity in PC12 cells by suppressing cell apoptosis and oxidative stress, Neurol. Res., 1 Yang, 2018, [MALAT1 inhibits proliferation and promotes apoptosis of SH-SY5Y cells induced by Aβ25-35 via blocking PI3K/mTOR/GSK3β pathway], Xi bao Yu fen zi mian Yi Xue za zhi chin, J. Cell. Mol. Immunol., 34, 434 Zhang, 2018, Silencing of long noncoding RNA SOX21-AS1 relieves neuronal oxidative stress injury in mice with Alzheimer's disease by upregulating FZD3/5 via the Wnt signaling pathway, Mol. Neurobiol., 10.1007/s12035-018-1299-y Jiang, 2016, Long non-coding RNA-MIAT promotes neurovascular remodeling in the eye and brain, Oncotarget, 7, 49688, 10.18632/oncotarget.10434 Zheng, 2017, Long nonding RNA UCA1 regulates neural stem cell differentiation by controlling miR-1/Hes1 expression, Am. J. Transl. Res., 9, 3696 Riva, 2016, The long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis, Curr. Alzheimer Res., 13, 1219, 10.2174/1567205013666160622112234 Geekiyanage, 2012, Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease, Exp. Neurol., 235, 491, 10.1016/j.expneurol.2011.11.026 Leidinger, 2013, A blood based 12-miRNA signature of Alzheimer disease patients, Genome Biol., 14, 10.1186/gb-2013-14-7-r78 Schneider, 2018, Genetic FTD Initiative (GENFI), Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study, J. Neurol. Neurosurg. Psychiatry, 89, 851, 10.1136/jnnp-2017-317492 Piscopo, 2018, Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia, J. Alzheimers Dis. JAD., 65, 455, 10.3233/JAD-180364 Derkow, 2018, Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease, PloS One, 13, 10.1371/journal.pone.0200602 Koh, 2014, Noninvasive in vivo monitoring of tissue-specific global gene expression in humans, Proc. Natl. Acad. Sci. U. S. A, 111, 7361, 10.1073/pnas.1405528111